Ultimate magazine theme for WordPress.

Innocan Pharma received U.S. FDA approval for their over the counter CBD pain relief line



Innocan Pharma (CSE: INNO) CEO Iris Bincovich joined Steve Darling from Proactive Vancouver with news the company has just received FDA approval in the …

source

Comments are closed.